In this double-blind study, 654 hypertensive patients (24-h mean ambulatory diastolic BP (MADBP) ⩾85 mm Hg) were randomized 1:1:1 to once-daily aliskiren 150 mg, irbesartan 150 mg or ramipril 5 mg. Doses were doubled after 2 weeks. At day 42, patients were again ...